Dublin - Research and Markets (http://www.researchandmarkets.com/research/4a4ba696/prostate_cancer)
has announced the addition of GlobalData's new report "Prostate Cancer
- Global Drug Forecasts and Treatment Analysis to 2020 - Q4 2010" to
Prostate Cancer - Global Drug Forecasts and Treatment Analysis to 2020
- Q4 2010 is an essential source of information and analysis on the
global prostate cancer therapeutics market. The report provides
comprehensive information on prostate cancer, highlighting the
treatment guidelines. It identifies and analyses the key trends
shaping and driving the global prostate cancer therapeutics market. It
analyses the treatment usage patterns in the global prostate cancer
therapeutics market. The report also provides insights into the
competitive landscape and the emerging players expected to
significantly alter the positions of the existing market leaders. The
report provides valuable insights into the pipeline products within
the global prostate cancer sector. It quantifies the unmet need in the
global prostate cancer therapeutics market as well as in the
individual markets such as the US and the top five countries in
Europe, highlighting the opportunity for future players.
The scope of the report includes:
- An overview of prostate cancer which includes epidemiology,
etiology, symptoms, diagnosis, pathology and treatment guidelines.
- Annualized global prostate cancer therapeutics market revenue,
annual cost of therapy and treatment usage patterns data (for hormone
therapy and hormone resistant or refractory therapy) from 2001 to
2009, forecast for 11 years to 2020.
Reasons to Buy:
The report will enhance your decision making capability. It will allow
- Develop business strategies and perform superior market
quantification analysis by
- Understanding the trends shaping and driving the global prostate
cancer therapeutics market.
- Understanding treatment preferences of physicians in disease state
and across treatment flow.
- Accessing market sizing, forecasts and quantified growth
opportunities in the global prostate cancer therapeutics market till
- Quantifying patient population in the global prostate cancer market
to better design product pricing & launch plans.
- Pfizer Inc.
- Bristol-Myers Squibb
- Takeda Pharmaceuticals
- Dendreon Corporation
- Johnson and Johnson
- Auron Healthcare GmbH
- Oncogenex Pharmaceuticals, Inc.
- Agennix AG
- GTx, Inc.
- GlaxoSmithKline plc
For more information visit http://www.researchandmarkets.com/research/4a4ba696/prostate_cancer
Source (News - Alert): GlobalData